Combination of DC-CIK and stem cell therapy effective to prevent cancer recurrence after surgery

NewsGuard 100/100 Score

"For brain cancer patients after surgery, the combined DC-CIK and stem cell therapy from Cellonis Biotechnologies can be a very effective method in preventing cancer recurrence," says renowned cancer doctor Dr. Dinggang Li. "This is a new hope for cancer patients".

The unique therapy combines the latest stem cell and immuno technology with the benefits of Traditional Chinese Medicine. Inger Marie Olsen from Norway has recently concluded a cycle of the treatment in Beijing, and she has been in a stable condition since the first cycle in September 2009.

Dr. Li has been guiding the treatment of Inger. "Inger's general condition has improved very much," he remarks. "She can now speak, move, eat and sleep much better, she has improved a great deal. I think her quality of life is almost back to normal."

"I was diagnosed with cancer in 2005," Inger explains in a recent interview. "I had chemotherapy, radiotherapy and three surgeries, but the cancer still came back. A friend of mine read about this new therapy on the internet and the people of my town arranged a fund to help me come here."

The Cellonis cancer therapy combines the latest research into cancer stem cells with the advantages of Traditional Chinese Medicine to create a unique cancer treatment. Dendritic cells, cultured and processed from blood taken from the patient's body, are loaded with glioma stem cell antigens to create a vaccine that can activate the immune system to kill cancer cells as well as the cancer stem cells responsible for tumor initiation and recurrence. Another patient like Inger with glioma who undertook the treatment earlier this year, Mr. Guy Spavold from Canada, has been in stable condition since April with a good quality of life.

"In my clinical experience patients with an advanced stage of brain tumor after surgery should be given this therapy to prevent cancer recurrence," continues Dr. Li. "For glioma patients this comprehensive therapy can be a real benefit and improve their life quality significantly."

Source:

Cellonis Biotechnologies Co., Ltd.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DASH diet may lower the risk of cardiovascular disease in breast cancer survivors